Detalhe da pesquisa
1.
Genetic instability and recurrent MYC amplification in ALK-translocated NSCLC: a central role of TP53 mutations.
J Pathol
; 246(1): 67-76, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29885057
2.
Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters.
Sci Rep
; 14(1): 13069, 2024 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38844820
3.
MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition.
J Thorac Oncol
; 19(1): 160-165, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37429463
4.
Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors.
Eur J Cancer
; 179: 124-135, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521334
5.
Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations.
Lung Cancer
; 144: 40-48, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32361034
6.
Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung Cancer.
JCO Precis Oncol
; 32019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32914023
7.
K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways.
J Thorac Oncol
; 14(4): 606-616, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30605727
8.
Clinical and Pathological Characteristics of KEAP1- and NFE2L2-Mutated Non-Small Cell Lung Carcinoma (NSCLC).
Clin Cancer Res
; 24(13): 3087-3096, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29615460
9.
Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors.
Nat Commun
; 9(1): 4655, 2018 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30405134
10.
The impact of sequencing on diagnosis and treatment of malignant melanoma.
Expert Rev Mol Diagn
; 16(4): 423-33, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26822148
11.
Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors.
Clin Cancer Res
; 22(19): 4837-4847, 2016 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27252416
12.
MET gene copy number alterations and expression of MET and hepatocyte growth factor are potential biomarkers in angiosarcomas and undifferentiated pleomorphic sarcomas.
PLoS One
; 10(4): e0120079, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25844809
13.
Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients.
J Thorac Oncol
; 10(7): 1049-57, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26102443